Home
Clinical Resources Search
PQI: Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

Download PQI pdf 0.19MB

Last Updated: September 27, 2023

By: Renee Shirakawa Kwock, PharmD, BCOP

About this PQI

The purpose of this PQI is to provide an outline on obinutuzumab and to provide guidance on clinical considerations for its optimal medication management.

More About This PQI

PQI:

Ibrutinib-Imbruvica-Expansion-with-Obinutuzumab-Gazyva_PQI_NCODA pdf 0.18MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Chronic Lymphocityic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Follicular Lymphoma (FL) Gazyva Obinutuzumab

PQI

PQI: Ibrutinib Dosing Optimization

Author: Nick Bouchard, PharmD | Danielle Maciorowski, PharmD

Frequently Searched

Supported by

Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

About this PQI

More About This PQI

PQI:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Vorasidenib (Voranigo®)

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Venetoclax (Venclexta®) Use in Chronic Lymphocytic Leukemia

PQI: Patient Screening for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI: Tazemetostat (Tazverik®) Management in Relapsed/Refractory Follicular Lymphoma

PQI: Initiating Mosunetuzumab-axgb (Lunsumio) in Relapsed/Refractory Follicular Lymphoma

PQI: Duvelisib (Copiktra®) for Chronic Lymphocytic Leukemia

PQI in Action: Tazemetostat (Tazverik®)Management in Relapsed/Refractory Follicular Lymphoma

PQI: Ibrutinib (Imbruvica®) Expansion with Obinutuzumab (Gazyva®)

PQI: Ibrutinib (Imbruvica®) Expansion with Obinutuzumab (Gazyva®)

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings